An insight into the early mechanisms of allergen-specific immunotherapy

Immunotherapy

Volumn 3, Issue 3, 2011, Pages 333-336

  Mitsias, Dimitris I ^a   Savvatianos, Savvas ^a   Papadopoulos, Nikolaos G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

allergen specific immunotherapy; apoptosis; desensitization; IDO; indoleamine 2,3 dioxygenase; inhibitory receptor; leukocyte immunoglobulin like receptor; LILR; rush protocol; tolerance; tryptophan starvation; venom

Indexed keywords

ALLERGEN; BEE VENOM; BLOCKING ANTIBODY; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN; WASP VENOM;

ANAPHYLAXIS; ARTICLE; BEE STING; CLINICAL PROTOCOL; DRUG MECHANISM; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

EID: 79952653964     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/imt.10.112     Document Type: Article

References (18)

1. Larche M, Akdis CA, Valenta R: Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6, 761-771 (2006). (Pubitemid 44453462)
2. James LK, Durham SR: Update on mechanisms of allergen injection immunotherapy. Clin.Exp. Allergy 38, 1074-1088 (2008).
3. Francis JN, James LK, Paraskevopoulos G et al.: Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J. Allergy Clin. Immunol. 121, 1120-1125 (2008).
4. Jutel M, Akdis M, Budak F et al.: IL-10 and TGF-b cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 33, 1205-1214 (2003). (Pubitemid 36609138)
5. Möbs C, Slotosch C, Löffler H, Jakob T, Hertl M, Pfützner W: Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation. J. Immunol. 184, 2194-2203 (2010).
6. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C: Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J. Allergy Clin. Immunol. 120, 707-713 (2007). (Pubitemid 47320765)
7. O'Hehir RE, Gardner LM, de Leon MP: House dust mite sublingual immunotherapy: the role for transforming growth factor-b and functional regulatory T cells. Am. J. Respir. Crit. Care Med. 180, 936-947 (2009).
8. Jutel M, Skrbic D, Pichler WJ, Müller UR: Ultra rush bee venom immunotherapy does not reduce cutaneous weal responses to bee venom and codeine phosphate. Clin. Exp. Allergy 25, 1205-1210 (1995). (Pubitemid 26016874)
9. Cernadas JR, Brockow K, Romano A et al.: General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 65, 1357-1366 (2010).
10. Sancho M, Simarro M, Castells M: Rapid IgE desensitization of mast cells impairs acute and late-phase activation responses and antigen internalization. J. Allergy Clin. Immunol. 125(Suppl. 1), AB238 (2010).
11. Takai T: A novel recognition system for MHC class I molecules constituted by PIR. Adv. Immunol. 88, 161-192 (2005). (Pubitemid 41437914)
12. Curti A, Trabanelli S, Salvestrini V, Baccarani M, Lemoli RM: The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood 113, 2394-2401 (2009).
13. Bussmann C, Xia J, Allam JP, Maintz L, Bieber T, Novak N: Early markers for protective mechanisms during rush venom immunotherapy. Allergy 65, 1558-1565 (2010).
14. Puccetti P, Grohmann U: IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kB activation. Nat. Rev. Immunol. 7, 817-823 (2007). (Pubitemid 47480306)
15. Held W, Mariuzza RA: cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat. Rev. Immunol. 8, 269-278 (2008). (Pubitemid 351432803)
16. Chang CC, Ciubotariu R, Manavalan JS et al.: Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3, 237-243 (2002). (Pubitemid 34218114)
17. Vlad G, Piazza F, Colovai A et al.: Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals. Hum. Immunol. 64, 483-489 (2003). (Pubitemid 36504687)
18. Brenk M, Scheler M, Koch S et al.: Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells. J. Immunol. 183, 145-154 (2009).